Delaet Ingrid: insider trades.
Delaet Ingrid reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($3.4M), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Delaet Ingrid
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Officer · Chief Regulatory Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Neurocrine Biosciences Inc | A | 4,483 | $0 | 20,708 | Form 4 |
| 2026-09-11 | Neurocrine Biosciences Inc | F | 2,419 | $156.22 | 18,289 | Form 4 |
| 2026-07-10 | Neurocrine Biosciences Inc | M | 4,367 | $106.02 | 20,592 | Form 4 |
| 2026-07-10 | Neurocrine Biosciences Inc | S | 4,367 | $181.02 | 16,225 | Form 4 |
| 2026-07-09 | Neurocrine Biosciences Inc | M | 8,433 | $103.52 | 24,658 | Form 4 |
| 2026-07-09 | Neurocrine Biosciences Inc | S | 8,433 | $178.72 | 16,225 | Form 4 |
| 2026-07-08 | Neurocrine Biosciences Inc | S | 2,737 | $178.54 | 16,225 | Form 4 |
| 2026-07-08 | Neurocrine Biosciences Inc | M | 2,737 | $103.52 | 18,962 | Form 4 |
| 2026-07-07 | Neurocrine Biosciences Inc | M | 3,401 | $103.52 | 19,626 | Form 4 |
| 2026-07-07 | Neurocrine Biosciences Inc | S | 3,401 | $178.57 | 16,225 | Form 4 |
Questions
What stock did Delaet Ingrid buy or sell?
Delaet Ingrid reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($3.4M), across 1 company.
Is Delaet Ingrid the same person as other filers with this name?
This page covers SEC CIK 1965808 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/delaet-ingrid-1965808.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.